The global antibody drug conjugates market in terms of revenue was estimated to be worth $9.7 billion in 2023 and is poised to reach $19.8 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028. This rapid growth is attributed to the increasing prevalence of cancer, advancements in ADC technology, and the successful approval and commercialization of several ADCs. Download the PDF Brochure at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122857391 #antibodydrugconjugates #antibodydrugconjugatesmarket